SCD and breast cancer: Accumulating studies have demonstrated that the inhibition of SCD1 by A939572 leads to the suppression of cancer cell proliferation and the induction of apoptosis in various types of solid cancers, including thyroid cancer [45], renal cell carcinoma [46], bladder cancer [47] and breast cancer [48].